ReviewAlzheimer's & dementia (Amsterdam, Netherlands)2021
Neuropsychiatric symptoms in Brazilians with mild cognitive impairment and dementia.
Review in Alzheimer's & dementia (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.
- Overlooked cases of mild cognitive impairment: Implications to early Alzheimer's disease.Ageing research reviews · 2024Pooled it
- The Pathology, Alzheimer's and Related Dementias Study (PARDoS): Design and Characteristics of the First 4,700+ Brazilian Participants.Neuroepidemiology · 2025Article
- Advancements in multi-omics research to address challenges in Alzheimer's disease: a systems biology approach utilizing molecular biomarkers and innovative strategies.Frontiers in aging neuroscience · 2025Review
- Neuropsychiatric symptoms and specific cognitive domains in mild cognitive impairment.Dementia & neuropsychologia · 2024Article
- Observational
- Reply to "Neuropsychiatric symptoms in community-dwelling older Brazilians with mild cognitive impairment and dementia".Alzheimer's & dementia (Amsterdam, Netherlands) · 2022Article
- Neuropsychiatric symptoms in community-dwelling older Brazilians with mild cognitive impairment and dementia.Alzheimer's & dementia (Amsterdam, Netherlands) · 2022Article
- Neuropsychiatric symptoms in Brazilians with mild cognitive impairment and dementia.Alzheimer's & dementia (Amsterdam, Netherlands) · 2021Review
Corrections and comments
- Erratum issuedErratum.2022
Authors and funding
7 authors at 2 institutions in 2 countries.
Funding
Abstract
introductionKnowledge is limited about behavioral and psychological symptoms of mild cognitive impairment (MCI) and dementia in racial and ethnic minorities.
methodsAs part of the Pathology, Alzheimer's and Related Dementias Study (PARDoS), we interviewed knowledgeable informants of 2319 older Brazilian decedents (67% white, 11% black, 22% mixed) using the informant portion of the Clinical Dementia Rating Scale to classify MCI and dementia and the Neuropsychiatric Inventory to assess behavioral and psychological symptoms.
resultsWe identified four clusters of neuropsychiatric symptoms: agitation, affect/apathy, psychosis, and behavioral problems. On the Clinical Dementia Rating Scale, 1407 had no cognitive impairment, 180 had MCI, and 732 had dementia. Both MCI and dementia were associated with symptoms in each behavioral/psychological cluster (all
conclusionMCI and dementia are associated with elevated behavioral and psychological symptoms in older black and white Brazilians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.